Summary
1. The effects of a novel cyclic AMP phosphodiesterase inhibitor, E-1020 (1,2-dihydro-6-methyl-2-oxo5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate), on cytosolic Ca++ level ([Ca++]cyt) and muscle tension were examined in rat aorta using a fluorescent Ca++ indicator, fura-2. 2. The sustained contraction induced by norepinephrine was more strongly inhibited by E-1020 than that induced by high K+. The contraction induced by a higher concentration of the stimulant was less sensitive to E-1020 than that due to a lower concentration. 3. Contractions induced by high K+ and norepinephrine followed the increase in [Ca++]cyt. E-1020 inhibited the increments in [Ca++]cyt and muscle tension. A Ca++ channel blocker, verapamil, inhibited the norepinephrine-stimulated [Ca++]cyt more strongly than the contraction. E-1020 inhibited the verapamil-insensitive portion of the norepinephrine-stimulated [Ca++]cyt and contraction. 4. Norepinephrine transiently increased [Ca++]cyt and muscle tension in Ca++-free solution. E-1020 inhibited the transient contraction but not the stimulated [Ca++]cyt. 5. E-1020 increased the cyclic AMP content of the muscle. The effects of E-1020 on cyclic AMP content and contraction were potentiated by an activator of adenylate cyclase, forskolin. 6. These results suggest that E-1020 inhibits the vascular contractility by the decrease in [Ca++]cyt and decrease in Ca++ sensitivity of contractile elements. These effects may be mediated by the increase in cyclic AMP content of the muscle.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abe A, Karaki H (1988) Inhibitory effects of forskolin on vascular smooth muscle of rabbit aorta. Jpn J Pharmacol 46:293–301
Abe A, Karaki H (1989) Effect of forskolin on cytosolic Ca++ level and contraction in vascular smooth muscle. J Pharmacol Exp Ther 249:895–900
Abe A, Karaki H (1990) The inhibitory effects of dibutyryl cyclic AMP on cytosolic Ca2+ and contraction in smooth muscle of rat aorta. Jpn J Pharmacol 52:342P
Bolton TB (1979) Mechanism of action of transmitters and other substances on smooth muscle. Physiol Rev 59:606–718
Furchgott RF, Zawadzki JV (1980) The obligatory role of ednothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (Lond) 288:373–376
Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440–3450
Karaki H (1989) Ca2+ localization and sensitivity in vascular smooth muscle. Trends Pharmacol Sci 10:320–325
Karaki H, Weiss GB (1984) Calcium channels in smooth muscle. Gastroenterology 87:960–970
Karaki H, Weiss GB (1988) Calcium release in smooth muscle. Life Sci 42:111–122
Karaki H, Sato K, Ozaki H (1988) Different effects of norepinephrine and KCl on the cytosolic Ca2+-tension relationship in vascular smooth muscle of rat aorta. Eur J Pharmacol 151:325–328
Karaki H, Sato K, Ozaki H (1991) Different effects of verapamil on cytosolic Ca2+ and contraction in norepinephrine-stimulated vascular smooth muscle. Jpn J Pharmacol 55:35–42
Kitazawa T, Kobayashi S, Horiuti K, Somlyo AV, Somlyo AP (1989) Receptor coupled, permeabilized smooth muscle. J Biol Chem 264:5339–5342
Konishi M, Olson A, Hollingworth S, Baylor SM (1988) Myoplasmic binding of fura-2 investigated by steady-state fluorescence and absorbance measurement. Biophys J 54:1089–1104
Kukovetz WR, Holzmann A, Wurm A, Pöch G (1979) Evidence for cyclic GMP-mediated relaxant effects of nitrocompounds in coronary smooth muscle. Naunyn-Schmiedeberg's Arch Pharmacol 310: 129–138
Lincoln TM, Fisher-Simpson V (1983) A comparison of the effects of forskolin and nitroprusside on cyclic nucleotide and relaxation in rat aorta. Eur J Pharmacol 101:17–27
Meddings JB, Scott RB, Fick GH (1989) Analysis and comparison of sigmoidal curves: application to dose-response data. Am J Physiol 257:G982-G989
Nishimura J, Kolber M, van Breemen C (1988) Norepinephrine and GTPγS increase myofilament Ca2+ sensitivity in alpha-toxin permeabilized arterial smooth muscle. Biochem Biophys Res Commun 157:677–683
Ohhara H, Ogawa T, Takeda M, Katoh H, Daiku Y, Igarashi T (1989) Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo [1,2-a] pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate: studies in dogs. Arzneim-Forsch Drug Res 39:38–45
Ogawa T, Ohhara H, Tsunoda H, Kuroki J, Shoji T (1989) Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo [1,2-a] pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate: studies on isolated guinea-pig cardiac muscles. Arzneim-Forsch Drug Res 39:33–37
Ozaki H, Sato K, Satoh T, Karaki H (1987) Simultaneous recordings of calcium signals and mechanical activity using fluorescent dye fura 2 in isolated strips of vascular smooth muscle. Jpn J Pharmacol 45:429–433
Ozaki H, Ohyama T, Sato K, Karaki H (1990) Ca2+-dependent and independent machanisms of sustained contraction in vascular smooth muscle. Jpn J Pharmacol 52:509–512
Sato K, Ozaki H, Karaki H (1988a) Changes in cytosolic calcium level in vascular smooth muscle strip measured simultaneously with contraction using fluorescent calcium indicator fura 2. J Pharmacol Exp Ther 246:294–300
Sato K, Ozaki H, Karaki H (1988b) Multiple effects of caffeine on contraction and cytosolic free Ca2+ levels in vascular smooth muscle of rat aorta. Naunyn-Schmiedeberg's Arch Pharmacol 338:443–448
Tajimi M, Ozaki H, Karaki H (1989) Effect of E-1020 on cytosolic calcium level and contraction in vascular smooth muscle. Jpn J Pharmacol 49:290P
Waldman SA, Rapaport RM, Murad F (1984) Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues. J Biol Chem 259:1432–1434
Weishaar RE (1987) Multiple molecular forms of phosphodiesterase: an overview. J Cyclic Nucleotide Protein Phos Res 11:463–472
Author information
Authors and Affiliations
Additional information
Send offprint requests to M. Täjimi at the above address
Rights and permissions
About this article
Cite this article
Tajimi, M., Ozaki, H., Sato, K. et al. Effect of a novel inhibitor of cyclic AMP phosphodiesterase, E-1020, on cytosolic Ca++ level and contraction in vascular smooth muscle. Naunyn-Schmiedeberg's Arch Pharmacol 344, 602–610 (1991). https://doi.org/10.1007/BF00170659
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00170659